Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Gastroesophageal Reflux Disease (GERD) Market Growth in 2025?

In recent years, the market size for gastroesophageal reflux disease (GERD) has experienced a minor increase. It is projected to expand from $5.25 billion in 2024 to reach $5.35 billion by 2025, reflecting a compound annual growth rate (CAGR) of 2.0%. The growth seen in the historic period could be linked to factors such as alterations in lifestyle and diet, the obesity crisis, heightened public awareness about GERD treatment, the worldwide expansion of the pharmaceutical industry, and increased investments towards GERD therapies.

What Is the Forecast for the Gastroesophageal Reflux Disease (GERD) Market Size Through 2029?

Predicted steady expansion is on the horizon for the gastroesophageal reflux disease (GERD) market, with an estimated growth to $5.94 billion by 2029, representing a compound annual growth rate (CAGR) of 2.7%. This projected growth for the forecast period can be linked to factors such as an aging demographic, increased healthcare expenditures, the emergence of biomarkers, more frequent GERD screening programs, a rise in heartburn prevalence, and heightened demand for medical devices. The forecast period is also expected to see key trends such as improved diagnostics and surgery methods, the creation of targeted therapies, and the increasing adoption of telehealth services.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12917&type=smp

What are the Key Market Players in Gastroesophageal Reflux Disease (GERD) Market and How They’re Evolving?

Major companies operating in the gastroesophageal reflux disease (GERD) market are GlaxoSmithKline PLC, SRS Life Sciences, Johnson & Johnson Services Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Reckitt Benckiser Group PLC, Eisai Co. Ltd., Pfizer Inc., Medtronic PLC, Teva Pharmaceuticals, HK inno.N Corporation, Sebela Pharmaceuticals, Mylan N.V., Bausch Health Companies Inc., Johnson & Johnson MedTech, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc., Almirall S.A., HK inno.N Corporation, SRS Life Sciences Pte. Ltd.

What Are the Primary Growth Drivers in the Gastroesophageal Reflux Disease (GERD) Market?

The escalating incidence of diseases affecting the esophagus is poised to stimulate the growth of the gastroesophageal reflux disease (GERD) market in the future. Esophageal diseases are health conditions that disrupt the functioning of the esophagus, the muscular channel that connects the mouth to the stomach. The principal goal of treating esophageal diseases is to relieve symptoms, enhance the quality of life and avert complications, thereby fostering enhanced health and wellbeing for individuals afflicted with gastroesophageal reflux disease. As an example, data from the American Cancer Society, a US-based professional body, showed that approximately 21,560 new cases of esophageal cancer are diagnosed annually in the United States, resulting in 16,120 mortalities due to esophageal cancer. Hence, the escalating incidence of esophageal diseases is spurring the growth of the gastroesophageal reflux disease (GERD) market. A significant surge in alcohol consumption is predicted to drive the growth of the gastroesophageal reflux disease (GERD) market in the coming years. Alcohol consumption pertains to the practice of consuming beverages containing ethanol, the sole type of alcohol considered safe for human consumption. The use of alcohol aggravates the development of GERD by reducing esophageal mobility and diminishing pressure levels. For example, data from the House of Commons Library, a UK-based library, revealed that in 2022, 56% of adults in England acknowledged consuming alcohol in the preceding week. The statistics exposed a gender divide in drinking habits, with 61% of males and 51% of females admitting to drinking alcohol during the specified period. Thus, the rising prevalence of alcohol consumption is fuelling the growth of the gastroesophageal reflux disease (GERD) market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12917&type=smp

What Are the Leading Segments in the Global Gastroesophageal Reflux Disease (GERD) Industry?

The gastroesophageal reflux disease (GERD) market covered in this report is segmented –

1) By Drug Type: Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist, EndoCinch, Stretta, EsophyX, Transoral Incisionless Fundoplication (TIF)

2) By Procedure: Invasive, Minimally Invasive

3) By End-Users: Hospital, Homecare, Specialty Clinics

Subsegments:

1) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide

2) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole

3) By H2 Receptor Blockers: Ranitidine, Famotidine, Nizatidine, Cimetidine

4) By Prokinetic Agents: Metoclopramide, Domperidone

5) By Dopamine Receptor Antagonists: Prochlorperazine, Droperidol

6) By EndoCinch: Endoscopic Suturing Systems

7) By Stretta: Radiofrequency Ablation Systems

8) By EsophyX: Transoral Fundoplication Systems

9) By Transoral Incisionless Fundoplication (TIF): TIF Devices And Systems

What Are the Key Market Trends in the Gastroesophageal Reflux Disease (GERD) Industry?

Leading firms in the gastroesophageal reflux disease (GERD) market are concentrating their efforts on developing and launching innovative GERD treatment devices to maintain their market dominance. For example, in April 2023, Laborie Medical Technologies, a medical tech organization based in the United States, introduced the state-of-the-art alpHaONE wireless pH-capsule reflux test diagnostic system that is designed specifically for detecting GERD. This system has the capability to monitor data for up to 96 hours, possess a sleek design with big buttons, and has a fail-proof capsule delivery system. Moreover, the system also incorporates a software application with a virtual instructional program, along with user-customized symptom buttons to enhance the user’s experience.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-gerd-global-market-report

What Is the Regional Outlook for the Gastroesophageal Reflux Disease (GERD) Market?

North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastroesophageal reflux disease (GERD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12917

This Report Delivers Insight On:

1. How big is the gastroesophageal reflux disease (gerd) market, and how is it changing globally?

2. Who are the major companies in the gastroesophageal reflux disease (gerd) market, and how are they performing?

3. What are the key opportunities and risks in the gastroesophageal reflux disease (gerd) market right now?

4. Which products or customer segments are growing the most in the gastroesophageal reflux disease (gerd) market?

5. What factors are helping or slowing down the growth of the gastroesophageal reflux disease (gerd) market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model